HOME >> MEDICINE >> NEWS
Molecular switch may turn off immune cells that target HIV

One of the primary mysteries of the AIDS epidemic why the immune system is unable to control HIV infection may have been solved by an international research collaborative. In an upcoming issue of Nature, the team reports how a molecular pathway involved in the immune cell "exhaustion" that characterizes several other chronic viral infections plays a similar role in HIV infection. They also found that blocking the pathway restores some function to HIV-specific CD8 and CD4 T cells. The paper from researchers at the Partners AIDS Research Center at Massachusetts General Hospital (MGH), the University of KwaZulu-Natal (UKZN) in South Africa, and other institutions has received early online publication.

"Back in 1987 our MGH team confirmed the existence of HIV-specific CD8 cells, the cytotoxic T lymphoctyes that should destroy virus-infected cells," says Bruce Walker, MD, director of the Partners AIDS Research Center (PARC) and principal investigator of the Nature study. "But it didn't make sense that these cells were found in high numbers in persons with late-stage disease (AIDS), indicating that they were somehow not doing their job. These new findings finally make sense out of our early discoveries and subsequent findings by others in the field: The immune cells are there, but they have been turned off in persons with high viral loads."

Several recent studies have shown that a molecular pathway involving a receptor called PD-1 (Programmed Death-1) inhibits the immune system in chronic viral infections those in which the immune system does not completely clear the virus. CD8 cells initially respond to viral infection by reproducing dramatically and producing cytokines that help destroy the viruses, but in chronic infection high levels of virus appear to overwhelm and exhaust CD8 cells. Recent studies in mice by Rafi Ahmed, PhD, of Emory University School of Medicine and Gordon Freeman, PhD, of Dana-Farber Cancer Institute both co-aut
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
20-Aug-2006


Page: 1 2 3

Related medicine news :

1. Elsevier launches Molecular Oncology
2. Molecular marker may help identify pancreatic cancer, and possibly predict survival time
3. Molecular differences between early and advanced melanomas could provide new drug targets
4. Molecular structure reveals how botulinum toxin attaches to nerve cells
5. Molecular medicine comes to the rescue
6. Molecular imaging may lead to earlier diagnosis of childhood respiratory virus
7. The Molecular Profiling Institute, Inc. and IBM advance technology
8. Molecular Profiling Institute secures $7.5 million in Series B funding
9. Molecular studies in cancer of the colon
10. Molecular ballet unravels, links proteins so cell can direct own movement
11. Molecular testing in patients with rare cancer predicts response to Gleevec

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Molecular switch may turn off immune cells that target HIV

(Date:6/18/2013)... 2013 By studying one of the most ... set of successful strategies in his article What We ... Case Study. , The inspirational brand Gollan refers to ... had an impressive 62 million followers (and rising). , ... Top Facebook Pages earlier this year. The Facebook data tracking ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... Physicians at University Hospitals Case Medical Center enrolled their ... clinical trial evaluating a novel, less-invasive procedure to help ... , Every year, more than 300,000 people in the ... their carotid artery. If left untreated, these blockages can ... causing a potentially disabling stroke, also known as a ...
(Date:6/18/2013)... Daniel Perlman has discovered a way to make phytosterol ... are consumed by humans, potentially opening the way to ... patent (#8,460,738) on the new process and composition was ... plants and cholesterol molecules in animals are highly similar ... to one another. When they mix in the gut ...
(Date:6/18/2013)... An international team of investigators co-led by Weill Cornell ... surgery and device research, similar to the kind of ... "Currently, there is no dynamic research framework to systematically ... to patients or may even be harmful," says co-lead ... , In the June 18 issue of the ...
Breaking Medicine News(10 mins):Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2Health News:Brandeis scientist invents anti-cholesterol process 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC announced ... a technology platform that connects buyers and sellers of ... an industry leader. Why? It,s because ... are intimately familiar with the dental industry. They have ... and have diligently worked to negotiate some of the ...
(Date:6/17/2013)... DIEGO , June 17, 2013 BioMed Realty ... its board of directors has declared a second quarter 2013 ... is equivalent to an annualized dividend of $0.94 per common ... on July 15, 2013 to stockholders of record at the ... About BioMed Realty Trust BioMed Realty delivers optimal ...
(Date:6/17/2013)... and TORONTO , June 17, ... today announced that it entered into a securities purchase ... The investors have agreed to purchase in a private ... newly designated non-voting Series E 9% Convertible Preferred Stock ... an aggregate of 100% of the shares of its ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
Cached News: